Evidence map›Paper›PMID 35862128›Full record

ArticleCirculation research2022

DC ENaC-Dependent Inflammasome Activation Contributes to Salt-Sensitive Hypertension.

Ashley Pitzer, Fernando Elijovich, Cheryl L Laffer, Lale A Ertuglu, Melis Sahinoz, Mohammad Saleem, Jaya Krishnan, Thanvi Dola, Luul A Aden, Quanhu Sheng and 9 more

Open access · greenAbstract read
In one paragraph

Article in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 88 citations in OpenAlex.

  1. Magnesium and blood pressure regulation: systemic and renal mechanisms.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Salt and chronic kidney disease.Nature reviews. Nephrology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Animal models of hypertension and concurrent organs injury.Animal models and experimental medicine · 2025
    Review
  19. Article
  20. [Mechanisms of pyroptosis in metabolic diseases].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Ashley PitzerDivision of Clinical Pharmacology (A.P., F.E., C.L.L., M. Saleem, J.K., T.D., L.A.A., D.M.P., A.K.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-5478-3886
Fernando ElijovichDivision of Clinical Pharmacology (A.P., F.E., C.L.L., M. Saleem, J.K., T.D., L.A.A., D.M.P., A.K.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-2511-056X
Cheryl L LafferDivision of Clinical Pharmacology (A.P., F.E., C.L.L., M. Saleem, J.K., T.D., L.A.A., D.M.P., A.K.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-6453-6010
Lale A ErtugluDivision of Nephrology (L.A.E., M. Sahinoz), Vanderbilt University Medical Center, Nashville, TN.
Melis SahinozDivision of Nephrology (L.A.E., M. Sahinoz), Vanderbilt University Medical Center, Nashville, TN.
Mohammad SaleemDivision of Clinical Pharmacology (A.P., F.E., C.L.L., M. Saleem, J.K., T.D., L.A.A., D.M.P., A.K.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0001-8091-8361
Jaya KrishnanDivision of Clinical Pharmacology (A.P., F.E., C.L.L., M. Saleem, J.K., T.D., L.A.A., D.M.P., A.K.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-9752-4219
Thanvi DolaDivision of Clinical Pharmacology (A.P., F.E., C.L.L., M. Saleem, J.K., T.D., L.A.A., D.M.P., A.K.), Vanderbilt University Medical Center, Nashville, TN.
Luul A AdenDivision of Clinical Pharmacology (A.P., F.E., C.L.L., M. Saleem, J.K., T.D., L.A.A., D.M.P., A.K.), Vanderbilt University Medical Center, Nashville, TN.
Quanhu ShengDepartment of Medicine, Department of Biostatistics (Q.S.), Vanderbilt University Medical Center, Nashville, TN.
Michael A RaddatzMedical Scientist Training Program, Vanderbilt University, Nashville, TN (M.A.R.).ORCID 0000-0001-8610-3489
Celestine WanjallaDivision of Infectious Diseases, Department of Internal Medicine (C.W., S.P.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0001-9159-5414
Suman PakalaDivision of Infectious Diseases, Department of Internal Medicine (C.W., S.P.), Vanderbilt University Medical Center, Nashville, TN.
Sean S DaviesDepartment of Pharmacology (S.S.D.), Vanderbilt University, Nashville, TN.ORCID 0000-0001-9879-8062
David M PatrickDivision of Clinical Pharmacology (A.P., F.E., C.L.L., M. Saleem, J.K., T.D., L.A.A., D.M.P., A.K.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-3412-447X
Valentina KonDepartment of Veterans Affairs, Nashville, TN (V.K.).
T Alp Ikizler
Thomas KleymanDepartments of Medicine, Cell Biology, Pharmacology and Chemical Biology, University of Pittsburgh, PA (T.K.).ORCID 0000-0002-2413-5415
Annet KiraboDivision of Clinical Pharmacology (A.P., F.E., C.L.L., M. Saleem, J.K., T.D., L.A.A., D.M.P., A.K.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0001-8580-9359
Vanderbilt University Medical Center · USDepartment of Veterans Affairs · AUThomas Jefferson University · USUniversity of California, Los Angeles · USVanderbilt University · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LINTON, MACRAE F · 2014 to 2025
$24.7M
Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CARATTINO, MARCELO DANIEL · 2008 to 2022
$13.4M
Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
ENaC regulation and its role in blood pressure homeostasisR01HL147818 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Annet Kirabo, Thomas R Kleyman · 2019 to 2026
$4.6M
UCSD PRIDE Faculty Development Program in Cardiovascular SciencesR25HL145817 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Robert Scott Ross, Joann Trejo · 2019 to 2026
$3.3M
Immune Mechanisms of Salt-Sensitive hypertensionR01HL144941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KIRABO, ANNET · 2021 to 2025
$3.0M
Salt Mediated Cross Talk Between Lymphatic Vessels and Immune Cells in Kidney DiseaseR01DK135764 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI VALENTINA KON, Annet Kirabo · 2023 to 2026
$2.9M
Vanderbilt Hypertension and Blood Pressure Regulation ProgramT32HL144446 · NHLBI · VANDERBILT UNIVERSITY · PI HARRISON, DAVID G · 2019 to 2023
$1.7M
Anti-cytomegalovirus Immune Responses in Atherosclerotic Cardiovascular Disease in Persons Living with HIVK23HL156759 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WANJALLA, CELESTINE N · 2021 to 2025
$860k
Role of Salt, Isoketal-modified Proteins and Dendritic Cells in HypertensionK01HL130497 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KIRABO, ANNET · 2016 to 2020
$803k
A Role of Isolevuglandin Adducts in Essential Hypertension and Systemic Lupus ErythematosusK08HL153789 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PATRICK, DAVID · 2020 to 2021
$317k
BLRD VA IK2 BX005376NCATS NIH HHS UL1 TR002243NHLBI NIH HHS K01 HL130497NHLBI NIH HHS K08 HL153789NHLBI NIH HHS K23 HL156759NHLBI NIH HHS P01 HL116263NHLBI NIH HHS R01 HL144941NHLBI NIH HHS R01 HL147818NHLBI NIH HHS R03 HL155041NHLBI NIH HHS R25 HL145817NHLBI NIH HHS T32 HL007444NHLBI NIH HHS T32 HL144446NIDDK NIH HHS P30 DK079307NIDDK NIH HHS R01 DK135764
6 · The paper itself

Abstract

backgroundSalt sensitivity of blood pressure is an independent predictor of cardiovascular morbidity and mortality. The exact mechanism by which salt intake increases blood pressure and cardiovascular risk is unknown. We previously found that sodium entry into antigen-presenting cells (APCs) via the amiloride-sensitive epithelial sodium channel EnaC (epithelial sodium channel) leads to the formation of IsoLGs (isolevuglandins) and release of proinflammatory cytokines to activate T cells and modulate salt-sensitive hypertension. In the current study, we hypothesized that ENaC-dependent entry of sodium into APCs activates the NLRP3 (NOD [nucleotide-binding and oligomerization domain]-like receptor family pyrin domain containing 3) inflammasome via IsoLG formation leading to salt-sensitive hypertension.

methodsWe performed RNA sequencing on human monocytes treated with elevated sodium in vitro and Cellular Indexing of Transcriptomes and Epitopes by Sequencing analysis of peripheral blood mononuclear cells from participants rigorously phenotyped for salt sensitivity of blood pressure using an established inpatient protocol. To determine mechanisms, we analyzed inflammasome activation in mouse models of deoxycorticosterone acetate salt-induced hypertension as well as salt-sensitive mice with ENaC inhibition or expression, IsoLG scavenging, and adoptive transfer of wild-type dendritic cells into NLRP3 deficient mice.

resultsWe found that high levels of salt exposure upregulates the NLRP3 inflammasome, pyroptotic and apoptotic caspases, and IL (interleukin)-1β transcription in human monocytes. Cellular Indexing of Transcriptomes and Epitopes by Sequencing revealed that components of the NLRP3 inflammasome and activation marker IL-1β dynamically vary with changes in salt loading/depletion. Mechanistically, we found that sodium-induced activation of the NLRP3 inflammasome is ENaC and IsoLG dependent. NLRP3 deficient mice develop a blunted hypertensive response to elevated sodium, and this is restored by the adoptive transfer of NLRP3 replete APCs.

conclusionsThese findings reveal a mechanistic link between ENaC, inflammation, and salt-sensitive hypertension involving NLRP3 inflammasome activation in APCs. APC activation via the NLRP3 inflammasome can serve as a potential diagnostic biomarker for salt sensitivity of blood pressure.

Indexed as

HypertensionInflammasomesAnimalsEpithelial Sodium ChannelsEpitopesHumansInterleukin-1betaLeukocytes, MononuclearMiceMice, Inbred C57BLNLR Family, Pyrin Domain-Containing 3 ProteinSodiumSodium ChlorideSodium Chloride, DietaryEpithelial Sodium ChannelsEpitopesInflammasomesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinSodiumSodium ChlorideSodium Chloride, Dietaryblood pressurecardiovascular diseasedeoxycorticosterone acetateinflammasomeisolevuglandins

Identifiers

PMID35862128
PMCPMC9357159
OpenAlexW4285041859

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.